Global DNA Fragmentation Technique Market, By Treatment Type (Assisted Reproductive Technology and Varicocele Surgery, Medication), Distribution Channel (Hospitals Pharmacies, Pharmacies and Drug Stores, Online Pharmacies), End User (Hospitals and Clinics, Fertility Centers, Research Institutes, Other End Users), Test Type (SCSA (Sperm Chromatin Structure Assay), TUNEL Assay, Halo Test, Comet Assay, Unexplained Infertility Treatment) – Industry Trends and Forecast to 2029
DNA Fragmentation Technique Market Analysis and Size
The market for DNA fragmentation technique is expected to grow during the forecast period. The most important factors fuelling the growth of the global market for advanced DNA fragmentation techniques include rising public awareness of the benefits and availability of these techniques, an increase in patients with lifestyle diseases and obesity, rising adoption of improved and more advanced assisted reproductive technologies, and a rise in the world's geriatric population.
Data Bridge Market Research analyses that the DNA fragmentation technique market which was USD 5.89 billion in 2021, would rocket up to USD 14.48 billion by 2029, and is expected to undergo a CAGR of 11.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment Type (Assisted Reproductive Technology and Varicocele Surgery, Medication), Distribution Channel (Hospitals Pharmacies, Pharmacies and Drug Stores, Online Pharmacies), End User (Hospitals and Clinics, Fertility Centers, Research Institutes, Other End Users), Test Type (SCSA (Sperm Chromatin Structure Assay), TUNEL Assay, Halo Test, Comet Assay, Unexplained Infertility Treatment)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Merck KGaA (Germany), SCSA Diagnostics Inc. (U.S.), Halotech DNA (Spain), Vitrolife (Sweden), Cadila Pharmaceuticals (India), The Cooper Companies Inc. (U.S.), Cryolab Ltd (U.K.), Microm UK Ltd. (U.K.), Thermo Fisher Scientific Inc. (U.S.), COVARIS LLC (U.S.), SeqLL Inc. (U.S.), SCSA Diagnostics (U.S.)
|
|
Market Opportunities
|
|
Market Definition
The splitting or breaking of DNA strands into pieces is known as DNA fragmentation. Cells can do it on purpose, laboratory workers can do it on purpose, or it can happen naturally. DNA fragmentation that occurs accidentally or spontaneously builds up over time in a cell. It can be determined, for instance, using the Comet test or the TUNEL assay.
DNA Fragmentation Technique Market Dynamics
Drivers
- Adoption of new technologies
Fragmentation of DNA is the first main step in preparing a sequencing library for NGS. The well-known NGS technologies such as Illumina or Ion Torrent generate a plethora of reads with lengths under 600–1000 bases.
Growing adoption of new and improved assisted reproductive technologies, an increase in the number of geriatric people around the world, and a rising infertility rate are some of the factors that are predicted to contribute to the growth of the DNA fragmentation technique market during the forecast period of 2022–2029. The market for DNA fragmentation techniques will expand during the forecast period due to rising medical tourism incidence and advanced technologies advancement.
- Rise in public awareness
The most important factors fuelling the growth of the global market for advanced DNA fragmentation techniques include rising public awareness of the benefits and availability of these techniques, an increase in patients with lifestyle diseases and obesity, rising adoption of improved and more advanced assisted reproductive technologies, and a rise in the world's geriatric population.
Opportunities
The DNA fragmentation technique market's growth is fuelled by an increase in the number of research and development activities. This will provide beneficial opportunities for the DNA fragmentation technique market growth.
Moreover, an increase in the number of emerging markets and new product launches will further provide beneficial opportunities for the DNA fragmentation technique market growth during the forecast period.
Restraints/Challenges
On the other hand, societal issues and treatment discontinuation will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the DNA fragmentation technique market.
This DNA fragmentation technique market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the DNA fragmentation technique market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global DNA Fragmentation Technique Market Scope
The DNA fragmentation technique market is segmented on the basis of treatment type, distribution channel, test type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment Type
- Assisted Reproductive Technology
- Varicocele Surgery
- Medication
Distribution Channel
- Hospitals Pharmacies
- Pharmacies and Drug Stores
- Online Pharmacies
End User
- Hospitals and Clinics
- Fertility Centers
- Research Institutes
- Other End Users
Test Type
- SCSA (Sperm Chromatin Structure Assay)
- TUNEL Assay
- Halo Test
- Comet Assay
- Unexplained Infertility Treatment
DNA Fragmentation Technique Market Regional Analysis/Insights
The DNA fragmentation technique market is analysed and market size insights and trends are provided by country, treatment type, distribution channel, test type and end user as referenced above.
The countries covered in the DNA fragmentation technique market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the DNA fragmentation technique market due to the prevalence of advanced and well-equipped fertility clinics along with rising awareness among the people.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the increasing occurrences of lifestyle diseases along with rising geriatric population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and DNA Fragmentation Technique Market Share Analysis
The DNA fragmentation technique market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to DNA fragmentation technique market.
Some of the major players operating in the DNA fragmentation technique market are:
- Merck KGaA (Germany)
- SCSA Diagnostics Inc. (U.S.)
- Halotech DNA (Spain)
- Vitrolife (Sweden)
- Cadila Pharmaceuticals (India)
- The Cooper Companies Inc. (U.S.)
- Cryolab Ltd (U.K.)
- Microm UK Ltd. (U.K.)
- Thermo Fisher Scientific Inc. (U.S.)
- COVARIS LLC (U.S.)
- SeqLL Inc. (U.S.)
- SCSA Diagnostics (U.S.)
SKU-